204 related articles for article (PubMed ID: 16545136)
1. The bone morphogenetic protein antagonist gremlin 1 is overexpressed in human cancers and interacts with YWHAH protein.
Namkoong H; Shin SM; Kim HK; Ha SA; Cho GW; Hur SY; Kim TE; Kim JW
BMC Cancer; 2006 Mar; 6():74. PubMed ID: 16545136
[TBL] [Abstract][Full Text] [Related]
2. Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization.
Ko J; Lee YH; Hwang SY; Lee YS; Shin SM; Hwang JH; Kim J; Kim YW; Jang SW; Ryoo ZY; Kim IK; Namkoong SE; Kim JW
Oncogene; 2003 Jul; 22(30):4679-89. PubMed ID: 12879013
[TBL] [Abstract][Full Text] [Related]
3. The bone morphogenetic protein antagonist Gremlin is overexpressed in human malignant mesothelioma.
Wang DJ; Zhi XY; Zhang SC; Jiang M; Liu P; Han XP; Li J; Chen Z; Wang CL
Oncol Rep; 2012 Jan; 27(1):58-64. PubMed ID: 21935575
[TBL] [Abstract][Full Text] [Related]
4. Cancer-associated expression of minichromosome maintenance 3 gene in several human cancers and its involvement in tumorigenesis.
Ha SA; Shin SM; Namkoong H; Lee H; Cho GW; Hur SY; Kim TE; Kim JW
Clin Cancer Res; 2004 Dec; 10(24):8386-95. PubMed ID: 15623617
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic protein-4 inhibitor gremlin is overexpressed in idiopathic pulmonary fibrosis.
Koli K; Myllärniemi M; Vuorinen K; Salmenkivi K; Ryynänen MJ; Kinnula VL; Keski-Oja J
Am J Pathol; 2006 Jul; 169(1):61-71. PubMed ID: 16816361
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of Gremlin 1 in cervical cancer and its effects on cancer stem cell maintenance.
Sato M; Kawana K; Fujimoto A; Yoshida M; Nakamura H; Nishida H; Inoue T; Taguchi A; Takahashi J; Adachi K; Nagasaka K; Matsumoto Y; Wada-Hiraike O; Oda K; Osuga Y; Fujii T
Oncol Rep; 2016 Jan; 35(1):391-7. PubMed ID: 26530461
[TBL] [Abstract][Full Text] [Related]
7. Differential gene expression and regulation of the bone morphogenetic protein antagonists follistatin and gremlin in normal and osteoarthritic human chondrocytes and synovial fibroblasts.
Tardif G; Hum D; Pelletier JP; Boileau C; Ranger P; Martel-Pelletier J
Arthritis Rheum; 2004 Aug; 50(8):2521-30. PubMed ID: 15334466
[TBL] [Abstract][Full Text] [Related]
8. Gremlin is overexpressed in lung adenocarcinoma and increases cell growth and proliferation in normal lung cells.
Mulvihill MS; Kwon YW; Lee S; Fang LT; Choi H; Ray R; Kang HC; Mao JH; Jablons D; Kim IJ
PLoS One; 2012; 7(8):e42264. PubMed ID: 22870311
[TBL] [Abstract][Full Text] [Related]
9. Expression of gremlin, a bone morphogenetic protein antagonist, in glomerular crescents of pauci-immune glomerulonephritis.
Mezzano S; Droguett A; Burgos ME; Aros C; Ardiles L; Flores C; Carpio D; Carvajal G; Ruiz-Ortega M; Egido J
Nephrol Dial Transplant; 2007 Jul; 22(7):1882-90. PubMed ID: 17403698
[TBL] [Abstract][Full Text] [Related]
10. Effects of TGF-beta2, BMP-4, and gremlin in the trabecular meshwork: implications for glaucoma.
Wordinger RJ; Fleenor DL; Hellberg PE; Pang IH; Tovar TO; Zode GS; Fuller JA; Clark AF
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1191-200. PubMed ID: 17325163
[TBL] [Abstract][Full Text] [Related]
11. Gremlin-mediated decrease in bone morphogenetic protein signaling promotes aristolochic acid-induced epithelial-to-mesenchymal transition (EMT) in HK-2 cells.
Li Y; Wang Z; Wang S; Zhao J; Zhang J; Huang Y
Toxicology; 2012 Jul; 297(1-3):68-75. PubMed ID: 22525892
[TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation.
Sneddon JB; Zhen HH; Montgomery K; van de Rijn M; Tward AD; West R; Gladstone H; Chang HY; Morganroth GS; Oro AE; Brown PO
Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14842-7. PubMed ID: 17003113
[TBL] [Abstract][Full Text] [Related]
13. In vivo delivery of Gremlin siRNA plasmid reveals therapeutic potential against diabetic nephropathy by recovering bone morphogenetic protein-7.
Zhang Q; Shi Y; Wada J; Malakauskas SM; Liu M; Ren Y; Du C; Duan H; Li Y; Li Y; Zhang Y
PLoS One; 2010 Jul; 5(7):e11709. PubMed ID: 20661431
[TBL] [Abstract][Full Text] [Related]
14. Dkk3, downregulated in cervical cancer, functions as a negative regulator of beta-catenin.
Lee EJ; Jo M; Rho SB; Park K; Yoo YN; Park J; Chae M; Zhang W; Lee JH
Int J Cancer; 2009 Jan; 124(2):287-97. PubMed ID: 19003969
[TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic proteins induce gremlin, a protein that limits their activity in osteoblasts.
Pereira RC; Economides AN; Canalis E
Endocrinology; 2000 Dec; 141(12):4558-63. PubMed ID: 11108268
[TBL] [Abstract][Full Text] [Related]
16. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
Han Y; San-Marina S; Yang L; Khoury H; Minden MD
Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
[TBL] [Abstract][Full Text] [Related]
17. Suppressor of cytokine signaling (SOCS)-3 protein interacts with the insulin-like growth factor-I receptor.
Dey BR; Furlanetto RW; Nissley P
Biochem Biophys Res Commun; 2000 Nov; 278(1):38-43. PubMed ID: 11071852
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of Oct-4 activity by Ewing's sarcoma protein.
Lee J; Rhee BK; Bae GY; Han YM; Kim J
Stem Cells; 2005; 23(6):738-51. PubMed ID: 15917470
[TBL] [Abstract][Full Text] [Related]
19. Mapping the heparin-binding site of the BMP antagonist gremlin by site-directed mutagenesis based on predictive modelling.
Tatsinkam AJ; Mulloy B; Rider CC
Biochem J; 2015 Aug; 470(1):53-64. PubMed ID: 26251446
[TBL] [Abstract][Full Text] [Related]
20. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
Dong-Dong L; Xi-Ran Z
Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
